<HashMap><database>biostudies-literature</database><scores/><additional><omics_type>Unknown</omics_type><volume>18(6)</volume><submitter>Ouaissi M</submitter><pubmed_abstract>&lt;h4>Aim&lt;/h4>To compare clinical presentation, operative management and short- and long-term outcomes of congenital bile duct cysts (BDC) in adults with children.&lt;h4>Methods&lt;/h4>Retrospective multi-institutional Association Francaise de Chirurgie study of Todani types I+IVB and IVA BDC.&lt;h4>Results&lt;/h4>During the 37-year period to 2011, 33 centers included 314 patients (98 children; 216 adults). The adult population included more high-risk patients, with more active, more frequent prior treatment (47.7% vs 11.2%; p &lt; 0.0001), more complicated presentation (50.5% vs 35.7%; p = 0.015), more synchronous biliary cancer (11.6% vs 0%; p = 0.0118) and more major surgery (23.6% vs 2%; p &lt; 0.0001), but this latter feature was only true for type I+IVB BDC. Compared to children, the postoperative morbi</pubmed_abstract><journal>HPB : the official journal of the International Hepato Pancreato Biliary Association</journal><pagination>529-39</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC4913142</full_dataset_link><repository>biostudies-literature</repository><pubmed_title>Congenital bile duct cyst (BDC) is a more indolent disease in children compared to adults, except for Todani type IV-A BDC: results of the European multicenter study of the French Surgical Association.</pubmed_title><pmcid>PMC4913142</pmcid><pubmed_authors>Meurisse N</pubmed_authors><pubmed_authors>Bentabak K</pubmed_authors><pubmed_authors>Molle G</pubmed_authors><pubmed_authors>Baulieux J</pubmed_authors><pubmed_authors>Sauvanet A</pubmed_authors><pubmed_authors>Dubois R</pubmed_authors><pubmed_authors>Pruvot FR</pubmed_authors><pubmed_authors>Risse O</pubmed_authors><pubmed_authors>Capussotti L</pubmed_authors><pubmed_authors>Geiss S</pubmed_authors><pubmed_authors>Mure PY</pubmed_authors><pubmed_authors>Gauthier F</pubmed_authors><pubmed_authors>Kianmanesh R</pubmed_authors><pubmed_authors>Duguet L</pubmed_authors><pubmed_authors>Ducerf C</pubmed_authors><pubmed_authors>Dane CT</pubmed_authors><pubmed_authors>Hubert C</pubmed_authors><pubmed_authors>Branchereau S</pubmed_authors><pubmed_authors>Giulante F</pubmed_authors><pubmed_authors>Martelli H</pubmed_authors><pubmed_authors>Demartines N</pubmed_authors><pubmed_authors>Msika S</pubmed_authors><pubmed_authors>Farges O</pubmed_authors><pubmed_authors>Doussot A</pubmed_authors><pubmed_authors>Wildhaber B</pubmed_authors><pubmed_authors>Roux A</pubmed_authors><pubmed_authors>Boudjema K</pubmed_authors><pubmed_authors>Ardito F</pubmed_authors><pubmed_authors>Gigot JF</pubmed_authors><pubmed_authors>Lebeau R</pubmed_authors><pubmed_authors>Falconi M</pubmed_authors><pubmed_authors>Revillon Y</pubmed_authors><pubmed_authors>Vibert E</pubmed_authors><pubmed_authors>Ayav A</pubmed_authors><pubmed_authors>Collet D</pubmed_authors><pubmed_authors>Graba A</pubmed_authors><pubmed_authors>Nuzzo G</pubmed_authors><pubmed_authors>Lerut J</pubmed_authors><pubmed_authors>Hardwigsen J</pubmed_authors><pubmed_authors>French Surgical Association</pubmed_authors><pubmed_authors>Balladur P</pubmed_authors><pubmed_authors>Cristaudi A</pubmed_authors><pubmed_authors>Adam R</pubmed_authors><pubmed_authors>Truant S</pubmed_authors><pubmed_authors>Rinaudo M</pubmed_authors><pubmed_authors>Laurent A</pubmed_authors><pubmed_authors>Salloum C</pubmed_authors><pubmed_authors>Langelle S</pubmed_authors><pubmed_authors>Sarnacki S</pubmed_authors><pubmed_authors>Laurain CA</pubmed_authors><pubmed_authors>Mansvelt B</pubmed_authors><pubmed_authors>Rat P</pubmed_authors><pubmed_authors>Castaing D</pubmed_authors><pubmed_authors>Cherqui D</pubmed_authors><pubmed_authors>Gelas T</pubmed_authors><pubmed_authors>Alhassane T</pubmed_authors><pubmed_authors>Vanlander A</pubmed_authors><pubmed_authors>Sa Cunha A</pubmed_authors><pubmed_authors>de Goyet Jde V</pubmed_authors><pubmed_authors>Paye F</pubmed_authors><pubmed_authors>Troisi R</pubmed_authors><pubmed_authors>Halkic N</pubmed_authors><pubmed_authors>Compagnon P</pubmed_authors><pubmed_authors>Mabrut JY</pubmed_authors><pubmed_authors>Irtan S</pubmed_authors><pubmed_authors>Reding R</pubmed_authors><pubmed_authors>Partensky C</pubmed_authors><pubmed_authors>Saviano M</pubmed_authors><pubmed_authors>Pirenne J</pubmed_authors><pubmed_authors>Adham M</pubmed_authors><pubmed_authors>Roberta G</pubmed_authors><pubmed_authors>Azoulay D</pubmed_authors><pubmed_authors>Ortega-Deballon P</pubmed_authors><pubmed_authors>Chafik B</pubmed_authors><pubmed_authors>Ragot E</pubmed_authors><pubmed_authors>Bouchoucha S</pubmed_authors><pubmed_authors>Otte JB</pubmed_authors><pubmed_authors>Le Treut YP</pubmed_authors><pubmed_authors>Baraket O</pubmed_authors><pubmed_authors>Letoublon C</pubmed_authors><pubmed_authors>Palot JP</pubmed_authors><pubmed_authors>Ouaissi M</pubmed_authors><pubmed_authors>Wassila O</pubmed_authors><pubmed_authors>Boleslawski E</pubmed_authors><pubmed_authors>Sommacale D</pubmed_authors><pubmed_authors>Sastre B</pubmed_authors><pubmed_authors>Ciacio O</pubmed_authors><pubmed_authors>Belghiti J</pubmed_authors><pubmed_authors>De Taffin G</pubmed_authors><pubmed_authors>Corfiotti F</pubmed_authors><pubmed_authors>Agostino Mde R</pubmed_authors><pubmed_authors>Gouillat C</pubmed_authors></additional><is_claimable>false</is_claimable><name>Congenital bile duct cyst (BDC) is a more indolent disease in children compared to adults, except for Todani type IV-A BDC: results of the European multicenter study of the French Surgical Association.</name><description>&lt;h4>Aim&lt;/h4>To compare clinical presentation, operative management and short- and long-term outcomes of congenital bile duct cysts (BDC) in adults with children.&lt;h4>Methods&lt;/h4>Retrospective multi-institutional Association Francaise de Chirurgie study of Todani types I+IVB and IVA BDC.&lt;h4>Results&lt;/h4>During the 37-year period to 2011, 33 centers included 314 patients (98 children; 216 adults). The adult population included more high-risk patients, with more active, more frequent prior treatment (47.7% vs 11.2%; p &lt; 0.0001), more complicated presentation (50.5% vs 35.7%; p = 0.015), more synchronous biliary cancer (11.6% vs 0%; p = 0.0118) and more major surgery (23.6% vs 2%; p &lt; 0.0001), but this latter feature was only true for type I+IVB BDC. Compared to children, the postoperative morbi</description><dates><release>2016-01-01T00:00:00Z</release><publication>2016 Jun</publication><modification>2025-04-04T07:28:44.237Z</modification><creation>2019-03-27T02:16:25Z</creation></dates><accession>S-EPMC4913142</accession><cross_references><pubmed>27317958</pubmed><doi>10.1016/j.hpb.2016.04.005</doi></cross_references></HashMap>